Walgreen Co. and Kroger Co. can sue Johnson & Johnson and Janssen Biotech Inc. for allegedly inflating prices for the biologic Remicade, despite an anti-assignment provision in a contract between wholesale drug distributors and the drugmakers, the Third Circuit said Friday.
Antitrust claims “are a product of federal statute and thus are extrinsic to, and not rights ‘under,’ a commercial agreement,” the U.S. Court of Appeals for the Third Circuit said in reversing summary judgment for the drugmakers.
J&J and Janssen thus couldn’t get out of the suit by claiming the right to sue belongs solely to the distributors, who ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.